The plant in Kabul, Afghanistan, is becoming a significant factor in the global supply market for Abacavir Sulphate drug substance. This Afghan manufacturing potential represents a substantial step onward for the Afghan pharmaceutical market and provides a valuable opportunity to lower dependence